• Live-Dead Cell Staining Kit for Biomaterial Assays

  2026-08-08

  Learn how Calcein-AM and Propidium Iodide dual staining can quantify cell survival in hydrogel, cytotoxicity, and wound-healing research. This workflow combines microscopy and flow cytometry guidance with practical controls, optimization steps, and troubleshooting for complex biomaterial systems.

• BRD4770 and the G9a Logic of Tumor Cell State

  2026-08-07

  BRD4770 is a G9a histone methyltransferase inhibitor that links H3K9 methylation, senescence, and tumor-cell proliferation. This thought-leadership guide translates evidence from PANC-1 pancreatic cancer models and a BRD4–RAC1 breast cancer study into a practical framework for target validation, assay design, and translational decision-making.

• UK-5099 (PF-1005023): Benchmarking Mitochondrial Pyruvate Ca

  2026-08-07

  UK-5099 (PF-1005023) is a potent, selective inhibitor of the mitochondrial pyruvate carrier, widely employed in mitochondrial metabolism research. It demonstrates strong in vitro and in vivo efficacy, with well-documented impacts on metabolic and immune pathways. The compound’s validated use in standardized immunometabolism protocols provides a robust tool for dissecting metabolic regulation of immune responses.

• Estradiol-ERα Inhibition of ER Stress Restores CD4+ T Cells

  2026-08-06

  This study demonstrates that estradiol, acting through ERα and GPR30, suppresses endoplasmic reticulum stress to restore both proliferation and cytokine production in splenic CD4+ T lymphocytes following hemorrhagic shock. The findings clarify estrogen receptor subtype-specific pathways in immune modulation post-trauma, offering mechanistic insights relevant to research on immune dysfunction, estrogen signaling, and therapy resistance.

• O-GlcNAcylation Drives Wnt-Induced Bone Formation via Glycol

  2026-08-06

  The referenced study uncovers how Wnt3a signaling promotes bone formation by inducing O-GlcNAcylation, which in turn rewires aerobic glycolysis in osteoblasts. This mechanistic insight highlights O-GlcNAcylation as an indispensable regulator of bone anabolism, offering potential new directions for osteoporosis research.

• EdU Imaging Kits (Cy5): Precision S-Phase Tracking in Stem C

  2026-08-05

  Discover how EdU Imaging Kits (Cy5) empower precise S-phase DNA synthesis measurement in hematopoietic stem cell studies. This article uniquely connects metabolic checkpoint discoveries to practical EdU assay decisions for advanced cell proliferation analysis.

• LY2228820 (P38 MAP Kinase Inhibitor): Precision Tools for Pa

  2026-08-05

  Explore how LY2228820, a potent p38 MAP kinase inhibitor, enables advanced dissection of cellular signaling in inflammation and cancer research. This article offers an in-depth, practical guide to leveraging its selectivity for robust pathway analysis.

• Tankyrase Inhibition Modulates Hippo Pathway in HCC Cells

  2026-08-04

  Jia et al. (2017) demonstrate that tankyrase 1/2 inhibitors, including G007-LK, suppress hepatocellular carcinoma (HCC) cell growth by modulating the Hippo-YAP signaling cascade. This work reveals a mechanistic link between tankyrase activity, AMOTL1/2 stabilization, and YAP inactivation, highlighting new therapeutic angles for liver cancer research.

• KG-501: Precision Disruption of CREB/CBP in Translational On

  2026-08-04

  Explore how KG-501, a selective CREB-KIX interaction inhibitor, is redefining transcriptional coactivator disruption and epigenetic modulation in translational oncology. This article synthesizes mechanistic insight, experimental protocol guidance, and strategic relevance for researchers aiming to remodel oncogenic signaling and the immune microenvironment in hard-to-treat cancers.

• MitMAB (SKU B7620): Reliable Dynamin Inhibition for Organoid

  2026-08-03

  This article offers scenario-driven, data-backed guidance for scientists using MitMAB (SKU B7620) to address reproducibility and mechanistic clarity in endocytosis and cellular uptake assays. Each section explores practical lab challenges—like model compatibility, assay optimization, and vendor selection—demonstrating how MitMAB's specificity and purity empower robust, interpretable results in organoid and cell-based workflows.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-08-03

  This study introduces a novel patient-derived gastric cancer assembloid model that integrates organoids with matched stromal cell subpopulations, closely recapitulating the tumor microenvironment. The assembloid platform enhances the physiological relevance of preclinical drug screening and provides new insights into resistance mechanisms and personalized therapy development.

• RCN2 Drives ESCC Metastasis and Chemoresistance via PI3K-AKT

  2026-08-02

  This study identifies reticulocalbin 2 (RCN2) as a key promoter of metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) through UBR5-mediated degradation of PPP2CA and consequent activation of the PI3K-AKT pathway. The findings highlight a novel molecular axis and therapeutic target for combating aggressive ESCC phenotypes.

• BMS 599626 dihydrochloride: Potent EGFR and ErbB2 Inhibitor

  2026-08-01

  BMS 599626 dihydrochloride is a nanomolar-range EGFR and ErbB2 inhibitor that suppresses cancer cell proliferation and tumor growth in vivo. It is widely utilized in breast and lung cancer research for dissecting receptor-driven oncogenic signaling. This article details its mechanism, benchmarks, and integration in translational workflows.

• 4-Phenylbutyric Acid: Advanced Strategies for ER Stress Assa

  2026-07-31

  Explore how 4-Phenylbutyric acid (4-PBA) enables advanced, reproducible ER stress alleviation in cell models. This article uniquely bridges molecular mechanism, recent assay innovations, and reference-driven protocol insights for rigorous apoptosis and autophagy research.

• Cy5 NHS ester(Et): Technical Guide for Protein Labeling Work

  2026-07-31

  Cy5 NHS ester(Et) is a water-soluble fluorescent dye optimized for covalent labeling of primary amine groups in proteins and biomolecules, supporting applications such as immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is not compatible with ethanol-based protocols or long-term storage of labeling solutions, and requires strict adherence to dissolution and handling guidelines for optimal performance.

443 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page